AKAmir Kugelman

Amir Kugelman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amir Kugelman has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Can We Enhance Long Term Respiratory Outcomes of Neonatal Pulmonary Diseases?

    by Amir Kugelman

    Infants born prematurely and infants born with neonatal pulmonary diseases are at risk for long term abnormal lung functions. In this review we will discuss efforts to enhance long term respiratory outcomes in premature infants, including the use of tracheostomy in those with severe bronchopulmonary dysplasia (BPD). We will further discuss long term respiratory abnormalities in newborns with congenital diaphragmatic hernia (CDH), representing infants with lung hypoplasia.


  • Open Access

    HHHFNC Versus NIPPV Delivered by Long Narrow Cannula in Preterm Infants: Randomized Noninferiority Trial

    by Ayala Gover, Tatiana Smolkin, Michal Molad, Karen Lavie‐Nevo, Adir Iofe, Rasha Zoabi‐Safadi, Arina Toropine, Rawnak Nazem Saab, Dan Waisman, Avi Rotschild, et al.

    Background: Heated humidified high flow (HHHFNC) and nasal intermittent positive pressure ventilation (NIPPV) delivered by cannula with long and narrow tubing (CLNT) are increasingly used in preterm infants for providing noninvasive respiratory support, due to their high comfort level and minimal nasal trauma. Despite their widespread use, no randomized controlled trial has been conducted so far. Objective: Determine whether HHHFNC is non‐inferior to CLNT‐NIPPV in providing respiratory support for preterm infants. Study Design: An unblinded, randomized controlled, non‐inferiority multicenter trial. Methodology: Preterm infants randomized to either HHHFNC or CLNT‐NIPPV. Infants born > 28 weeks of gestation were eligible to enter the study either as primary treatment after birth or post‐extubation. Infants born ≤ 28 weeks of gestation were only eligible post‐extubation. The primary outcome was treatment failure within 7 days. Results: One hundred and thirty infants were enrolled in the study; 65 in each group. Most (82%) were > 28 weeks, and primary treatment (73%). HHHFNC was non‐inferior to CLNT‐NIPPV in the primary outcome which occurred in 12.3% compared to 23.0% of the infants, respectively (risk difference (RD) −10.77%, 95% CI of RD −23.7 to 2.22 [within the non‐inferiority margin], χ 2 p = 0.168). HHHFNC was associated with significantly less nasal trauma compared to CLNT‐NIPPV but with longer time on the allocated respiratory support. No significant differences were found between the groups in secondary respiratory and neonatal outcomes. Conclusions: In this study of preterm infants mostly > 28 weeks of gestation, HHHFNC was non‐inferior to CLNT‐NIPPV in providing respiratory support, and caused less nasal trauma.

  • Open Access

    A Moving Target: Studying the Effect of Continuous Transcutaneous CO2 Monitoring in ELBW Infants During an Equipoise Shift

    by Liron Borenstein-Levin, Noa Avishay, Ori Hochwald, Orit Soffer, Shmuel Arnon, Arieh Riskin, Ayala Gover, Karen Lavie-Nevo, Alon Haham, Justin Richardson, et al.

    Objectives: To assess whether continuous non-invasive pCO2 monitoring by transcutaneous pCO2 monitor (TCpCO2) among extremely low birth weight (ELBW) premature infants, during the first week of life, will decrease the rate of high-grade intraventricular hemorrhage (IVH) or periventricular leukomalacia (PVL) or the combined outcome of IVH/PVL and death. Methods: This was a prospective, observational, multicenter study. Due to ethical constraints, allocation was based on TCpCO2 monitor availability. ELBW infants were either monitored by TCpCO2 monitor (Sentec, Therwil, Switzerland) (study group), or recruited to the control group if a TCpCO2 monitor was not available. Results: A total of 132 ELBW infants participated in the study. The size of the study group (106 infants) and the control group (26 infants) differed because monitor availability increased during the study period reflecting change in standard of care. The groups had comparable gestational age and baseline characteristics. No difference was found in the rate of IVH/PVL in the study vs. control groups (10% vs. 4%; p = 0.7, respectively), or in the combined outcome of PVL/IVH and death (16% vs. 15%; p = 1.0, respectively). Conclusions: This study demonstrates the challenges in conducting a prospective controlled trial in a rapidly evolving medical field. While the study began with a clear equipoise, this balance shifted as the care team gained more experience with TCpCO2 monitoring among the study population, despite the absence of new clinical evidence to justify such a shift. Consequently, the small control group limited our ability to draw definitive conclusions regarding the study’s objective. However, our findings may increase awareness of continuous non-invasive pCO2 monitoring in extremely premature infants.


  • Striving for healthy lungs: Enhancing respiratory outcomes of prematurity

    by Amir Kugelman

    Infants born prematurely are born in a critical developmental time period and because of arrest of lung maturation at that period their pulmonary functions are below the normal for their age. Early lung development has a lifelong effect on respiratory health and disease. Can we affect that sequence of events and change the outcome of chronic lung disease of prematurity?


  • Open Access

    Transcutaneous CO2 Monitoring in Extremely Low Birth Weight Premature Infants

    by Liron Borenstein-Levin, Noa Avishay, Orit Soffer, Shmuel Arnon, Arieh Riskin, Gil Dinur, Karen Lavie-Nevo, Ayala Gover, Amir Kugelman, Ori Hochwald

    Extremely low birth weight (ELBW) premature infants are particularly susceptible to hypocarbia and hypercarbia, which are associated with brain and lung morbidities. Transcutaneous CO2 (TcCO2) monitoring allows for continuous non-invasive CO2 monitoring during invasive and non-invasive ventilation and is becoming more popular in the NICU. We aimed to evaluate the correlation and agreement between CO2 levels measured by a TcCO2 monitor and blood gas CO2 (bgCO2) among ELBW infants. This was a prospective observational multicenter study. All infants < 1000 g admitted to the participating NICUs during the study period were monitored by a TcCO2 monitor, if available. For each bgCO2 measured, a simultaneous TcCO2 measurement was documented. In total, 1828 pairs of TcCO2–bgCO2 values of 94 infants were collected, with a median (IQR) gestational age of 26.4 (26.0, 28.3) weeks and birth weight of 800 (702, 900) g. A moderate correlation (Pearson: r = 0.64) and good agreement (bias (95% limits of agreement)):(2.9 [−11.8, 17.6] mmHg) were found between the TcCO2 and bgCO2 values in the 25–70 mmHg TcCO2 range. The correlation between the TcCO2 and bgCO2 trends was moderate. CO2 measurements by TcCO2 are in good agreement (bias < 5 mmHg) with bgCO2 among premature infants < 1000 g during the first week of life, regardless of day of life, ventilation mode (invasive/non-invasive), and sampling method (arterial/capillary/venous). However, wide limits of agreement and moderate correlation dictate the use of TcCO2 as a complementary tool to blood gas sampling, to assess CO2 levels and trends in individual patients.


  • Open Access

    Cardiopulmonary Exercise Testing in Childhood in Late Preterms: Comparison to Early Preterms and Term-Born Controls

    by Ori Hochwald, Lea Bentur, Yara Haddad, Moneera Hanna, Merav Zucker-Toledano, Gur Mainzer, Julie Haddad, Michal Gur, Liron Borenstein-Levin, Amir Kugelman, et al.

    Background: Late preterm (340–366 weeks gestational age [GA]) infants may have abnormal pulmonary development and possible exercise physiology parameters. We aim to assess the effect of late prematurity on exercise capacity in childhood and to compare it to early preterm (EP) (born < 300 GA), and to term healthy control (TC) (>370 week GA). Methods: Late preterm and early preterm (7–10 years) completed a cardiopulmonary exercise test (CPET) and spirometry and were compared to EP and to TC. Results: Eighty-four children (age 9.6 ± 1.0 years, 48% girls) participated. Twenty-one former LP were compared to 38 EP (15 with Bronchopulmonary dysplasia (BPD) [EP+], 23 without BPD [EP−]) and to 25 TC children. Peak oxygen uptake (peakV̇O2) was statistically lower than in the TC, but within the normal range, and without difference from the EP (LP 90.2 ± 15.1%, TC 112.4 ± 16.9%, p < 0.001; EP+ 97.3 ± 25.5%, EP− 85.4 ± 20.8%, p = 0.016 and p < 0.001, respectively, when compared with TC). Lung function (FEV1) was lower than normal only in the EP+ (75.6 ± 14.9% predicted, compared with 12.5 ± 87.8 in EP−, 87.5 ± 16.9 in LP and 91.0 ± 11.7 in TC). Respiratory and cardiac limitations were similar between all four study groups. Conclusions: This study demonstrated lower exercise capacity (peakV̇O2) in former LP children compared with healthy term children. Exercise capacity in LP was comparable to that of EP, with and without BPD. However, the exercise test parameters, specifically peakV̇O2, were within the normal range, and no significant physiological exercise limitations were found.


  • Effects of neurodevelopmental risk factors on brainstem maturation in premature infants

    by L. Borenstein-Levin, R. Taha, A. Riskin, H. Hafner, A. Cohen-Vaizer, A. Gordin, Y. Littner, G. Dinur, O. Hochwald, A. Kugelman

    Background Interpeak latencies (IPL), as measured by the auditory brainstem-evoked responses (ABR) test, represent the conduction time, and therefore the maturation of the brainstem auditory pathway. We aimed to study the effect of various risk factors for the neurodevelopmental delay on the conduction time in the auditory pathway among normal hearing premature infants, at term postmenstrual age (PMA). Methods Retrospective analysis of 239 premature infants (gestational age 32.5 ± 2.1 weeks, birth weight 1827 ± 483 g). Interpeak latencies, demographic data, and risk factors were recorded. Results Sex, PMA at ABR test, being small for gestational age (SGA), intraventricular hemorrhage (IVH) or periventricular leukomalacia (PVL), and days of invasive ventilation were found to significantly affect the IPL’s in the auditory pathway in a univariate analysis. Multivariable regression analysis revealed that male sex and less advanced PMA at the examination were independent factors associated with prolonged IPL’s, while bronchopulmonary dysplasia, IVH or PVL and being SGA shortened the IPL’s. Non-invasive mechanical ventilation, did not affect the caudal part of the auditory pathway, despite its high noise level. Conclusions Among various risk factors for the neurodevelopmental delay, male sex was associated with delayed, while IVH or PVL, BPD and SGA could be associated with accelerated auditory brainstem maturation. Impact Auditory brainstem-evoked response (ABR) test, among normal hearing infants, can serve as a clinical tool to assess brainstem auditory maturation. Different neurodevelopmental risk factors could have different effects on the maturity of the auditory pathway. Male sex is significantly associated with prolonged interpeak latencies (IPL) among preterm and term infants, while intraventricular hemorrhage or periventricular leukomalacia, bronchopulmonary dysplasia, and being small for gestation age may be associated with shortened IPL The corrected age at ABR testing is of significance, among preterm and term infants.


  • Respiratory morbidity in very low birth weight infants through childhood and adolescence

    by Yoav Littner, Chen Volinsky, Jacob Kuint, Naama Yekutiel, Liron Borenstein‐Levin, Gil Dinur, Ori Hochwald, Amir Kugelman

    Objective: To describe the long‐term (up to 18 years of age) respiratory outcomes of children and adolescents born at very low birth weight (VLBW; ≤1500 g) in comparison with that of children born >1500 g.Methods: An observational, longitudinal, retrospective study comparing VLBW infants with matched controls, registered at a large health maintenance organization in Israel. Pulmonary outcomes collected anonymously from the electronic medical files included respiratory illness diagnoses, purchased medications for respiratory problems, office visits with either a pediatric pulmonologist or cardiologist and composite respiratory morbidity combining all these parameters.Results: Our study included 5793 VLBW infants and 11,590 matched controls born between 1998 and 2012. The majority (99%) of VLBW infants were premature (born < 37 weeks' gestation), while 93% of controls were born at term. The composite respiratory morbidity was significantly higher in VLBW infants compared with controls in all age groups (relative risk [95% confidence interval]: 1 year: 1.22 [1.19–1.26], <2 years: 1.30 [1.27–1.34], 2–6 years: 1.29 [1.27–1.32], 6–12 years: 1.53 [1.47–1.59], 12–18 years: 1.46 [1.35–1.56]; respectively). Both VLBW infants and controls demonstrated a steady decline in the composite respiratory morbidity with aging. In VLBW infants, lower gestational age was associated with higher respiratory morbidity only until 2 years of age and the morbidity declined in each gestational age group until adolescence.Conclusion: Our study confirmed a strong association between VLBW and pulmonary morbidity. The higher prevalence of respiratory composite morbidity in VLBW infants persists over the years until adolescence. The respiratory morbidity is most evident in the first year of life and declines afterward.


  • Oxygenation Instability Assessed by Oxygen Saturation Histograms during Supine vs Prone Position in Very Low Birthweight Infants Receiving Noninvasive Respiratory Support

    by Adi Miller-Barmak, Arieh Riskin, Ori Hochwald, Julie Haddad, Gil Dinur, Rita Vortman, Amir Kugelman, Liron Borenstein-Levin


  • High-flow nasal cannula therapy: can it be recommended as initial or rescue care for infants with moderate bronchiolitis in the paediatric ward?

    by Amir Kugelman

    The current literature does not support routine or initial use of HFNC in infants with moderate bronchiolitis – unless criteria for use are more selective. Rescue HFNC might be justified if the threshold for standard care failure is better delineated.https://bit.ly/3a9oEXb